Clinical trial
EXploring Inflammation and Social deTerminants (EXIST) Study in Breast Cancer Patients
NCT07478016 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EXploring Inflammation and Social deTerminants (EXIST) Study in Breast Cancer Patients
- Lead sponsor
- Thomas Jefferson University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 21, 2022
- Completion date
- December 31, 2028
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, ductal carcinoma in situ